Nosocomial Acinetobacter baumannii bloodstream infections occur with significant
prevalence and mortality. The relationship between carbapenem resistance in A. baumannii …

Carbapenems are considered the treatment of choice for Acinetobacter baumannii
infections. Many facilities implement preventive measures toward only carbapenem-resistant …

Acinetobacter baumannii has become a leading cause of bloodstream infections (BSI) in
health care settings. Although the incidence of infection with carbapenem-and ampicillin …

Objective. To characterize the clinical outcomes of patients with bloodstream infection
caused by carbapenem-resistant Acinetobacter baumannii during a 2-state monoclonal …

The incidence of carbapenem-resistant Acinetobacter baumannii infection is increasing,
which might be associated with high morbidity and mortality among critically ill patients with …

Acinetobacter baumannii has emerged as a major cause of healthcare-associated
infections. Controversy exists as to whether antimicrobial resistance increases the risk of …

Background: Carbapenem-resistant Acinetobacter baumannii (CRAB) is a rapidly emerging,
life-threatening nosocomial infection. This study aimed to explore the risk factors, clinical …

Background/Purpose Identification of risks of mortality for carbapenem-resistant
Acinetobacter baumannii (CRAB), with early implementation of an appropriate therapy, is …

BACKGROUND: Risk factors and outcome in patients who acquire nosocomial infections
due to carbapenem-resistant Acinetobacter baumannii (CRAB) are rarely investigated …

Background Carbapenem-resistant Acinetobacter baumannii (CRAB) tops the list of threats
to human health. Studies exploring predictors of mortality in patients with CRAB infection …